Long acting beta<sub>2</sub> agonists: are they safe?

Bandula Wijesiriwardena

doi:10.4038/cmj.v51i4.1140

Leading Article

Long acting beta₂ agonists: are they safe?

Author:

Bandula Wijesiriwardena

Colombo South Teaching Hospital, Kalubowila, LK

X close

Abstract

doi: 10.4038/cmj.v51i4.1140

Ceylon Medical Journal Vol. 51, No. 4, Dec 2006 pp129-131

Keywords: beta-agonists

How to Cite: Wijesiriwardena, B., (2009). Long acting beta₂ agonists: are they safe?. Ceylon Medical Journal. 51(4), pp.129–131. DOI: http://doi.org/10.4038/cmj.v51i4.1140

Published on 29 Sep 2009.

No License

Downloads

PDF (EN)

Wijesiriwardena, B., (2009). Long acting beta₂ agonists: are they safe?. Ceylon Medical Journal. 51(4), pp.129–131. DOI: http://doi.org/10.4038/cmj.v51i4.1140

Wijesiriwardena B. Long acting beta₂ agonists: are they safe?. Ceylon Medical Journal. 2009;51(4):129–31. DOI: http://doi.org/10.4038/cmj.v51i4.1140

Wijesiriwardena, B. (2009). Long acting beta₂ agonists: are they safe?. Ceylon Medical Journal, 51(4), 129–131. DOI: http://doi.org/10.4038/cmj.v51i4.1140

Wijesiriwardena, Bandula. 2009. Long acting beta₂ agonists: are they safe? 51, no. 4: 129–131. DOI: http://doi.org/10.4038/cmj.v51i4.1140

Ceylon Medical Journal

Reading: Long acting beta2 agonists: are they safe?